866-997-4948 (US-Canada Toll Free)

Eurocine Vaccines AB - Product Pipeline Review - 2012

Published By :

Global Markets Direct

Published Date : 2012-09-25

Category :

Pharmaceutical

No. of Pages : 23

Product Synopsis

Eurocine Vaccines AB Product Pipeline Review 2012 Global Market Directs pharmaceuticals report, Eurocine Vaccines AB Product Pipeline Review 2012 provides data on the Eurocine Vaccines ABs research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.  This report is built using data and information sourced from Global Markets Directs proprietary databases, Eurocine Vaccines ABs corporate website, SEC filings, investor presentations and featured press releases, both from Eurocine Vaccines AB and industry-specific third party sources, put together by Global Markets Directs team.  Scope Eurocine Vaccines AB Brief... Read More

Table Of Content

Table of Contents

Table of Contents 2

List of Tables 3
List of Figures 3
Eurocine Vaccines AB Snapshot 4
Eurocine Vaccines AB Overview 4
Key Information 4
Key Facts 4
Eurocine Vaccines AB Research and Development Overview 5
Key Therapeutic Areas 5
Eurocine Vaccines AB Pipeline Review 7
Pipeline Products by Stage of Development 7
Pipeline Products Monotherapy 8
Eurocine Vaccines AB Pipeline Products Glance 9
Eurocine Vaccines AB Clinical Stage Pipeline Products 9
Phase I Products/Combination Treatment Modalities 9
Eurocine Vaccines AB Early Stage Pipeline Products 10
Pre-Clinical Products/Combination Treatment Modalities 10
Eurocine Vaccines AB Drug Profiles 11
Immunose FLU 11
Product Description 11
Mechanism of Action 11
R&D Progress 11
Nasal Pneumococcal Vaccine 13
Product Description 13
Mechanism of Action 13
R&D Progress 13
Eurocine Vaccines AB Pipeline Products by Route of Administration 14
Eurocine Vaccines AB Recent Pipeline Updates 15
Eurocine Vaccines AB Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Eurocine Vaccines AB, Recent Developments 17
Eurocine Vaccines AB- Press Release 17
Jan 04, 2012: Eurocine Vaccines, Bionor Pharma And Oslo University Announce Full Enrollment Of Nasal Immunization Study Of Vacc4x And Endocine 17
Dec 03, 2009: Eurocine Vaccines Clinical Trial Fully Recruited 17
Oct 07, 2009: Eurocine Vaccines Begins Nasal Influenza Vaccine Study In Humans 18
Financial Deals Landscape 19
Eurocine Vaccines AB, Deals Summary 19
Eurocine Vaccines AB, Pharmaceuticals & Healthcare, Deal Details 20
Partnerships 20
Eurocine Vaccines Enters Into Collaboration With HeliCure 20
Equity Offering 21
Eurocine Vaccines Completes Private Placement Of Shares For $1.8 Million 21

Appendix 22
Methodology 22
Coverage 22
Secondary Research 22
Primary Research 22
Expert Panel Validation 22
Contact Us 23
Disclaimer 23

List of Tables


Eurocine Vaccines AB, Key Information 4
Eurocine Vaccines AB, Key Facts 4
Eurocine Vaccines AB Pipeline by Indication, 2012 6
Eurocine Vaccines AB Pipeline by Stage of Development, 2012 7
Eurocine Vaccines AB Monotherapy Products in Pipeline, 2012 8
Eurocine Vaccines AB Phase I, 2012 9
Eurocine Vaccines AB Pre-Clinical, 2012 10
Eurocine Vaccines AB Pipeline By Route of Administration, 2012 14
Eurocine Vaccines AB Recent Pipeline Updates, 2012 15
Eurocine Vaccines AB, Subsidiaries 16
Eurocine Vaccines AB, Deals Summary 19
Eurocine Vaccines Enters Into Collaboration With HeliCure 20
Eurocine Vaccines Completes Private Placement Of Shares For $1.8 Million 21

List of Figures


Eurocine Vaccines AB Pipeline by Indication, 2012 6
Eurocine Vaccines AB Pipeline by Stage of Development, 2012 7
Eurocine Vaccines AB Monotherapy Products in Pipeline, 2012 8

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *

Upcoming Reports

  • Advanced Parenteral Drug Delivery Devices Market - Upcoming Technologies, Current Trends, Global Industry Size, Share, Analysis And Forecast (2012 - 2018)

    By - Transparency

    Increasing number of new biological products and emergence of new biosimilars is focusing the attention towards the development of advanced drug delivery technologies for delivery of these biological products. Currently, oral and parenteral drug delivery technologies are dominating the global drug delivery market. Despite various technological innovations and discovery of more compelling and effective methods for drug delivery, parenteral method remains most dominant due to its effective results.   Parenteral drug delivery is one of the largest segments of drug delivery...

  • Greece: market of machines for the reception, conversion and transmission of voice, images or data

    By - Williams and Marshal Strategy

    This report presents a comprehensive overview of the machines for the reception, conversion and transmission of voice, images or data market in Greece and its state as of January 2014. It provides detailed analysis of the industry, its dynamics and structure. The purpose of the report is to describe the state of the machines for the reception, conversion and transmission of voice, images or data market in Greece, to present actual and retrospective information about the volumes and dynamics of production, imports, exports and consumption, the characteristics of the market for the period...

  • Virtual Reality (VR) In Healthcare Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019

    By - Transparency

    Advancement in healthcare IT is changing the dimensions of how a patient is being treated and provides services by a healthcare practitioner. Conventional devices and therapies are getting replaced by newer technologies and software enabled healthcare solutions. An emerging technology in this spectrum is of virtual reality, a computer enabled three dimensional interactive worlds simulating a desired environment. Though in its nascent stage of commercialization, virtual reality technology in is adopted among the department of defense, medical schools and hospitals, and manufacturers of...